Secor Capital Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-8,927
| Closed | -$637K | – | 472 |
|
|
2018
Q4 | $637K | Buy |
8,927
+1,876
| +27% | +$134K | 0.08% | 239 |
|
|
2018
Q3 | $867K | Buy |
+7,051
| New | +$867K | 0.09% | 223 |
|
|
2018
Q1 | – | Sell |
-19,607
| Closed | -$1.52M | – | 537 |
|
|
2017
Q4 | $1.52M | Buy |
+19,607
| New | +$1.52M | 0.06% | 200 |
|
|
2017
Q2 | – | Sell |
-72,270
| Closed | -$3.13M | – | 470 |
|
|
2017
Q1 | $3.13M | Buy |
72,270
+681
| +1% | +$29.5K | 0.34% | 80 |
|
|
2016
Q4 | $2.77M | Buy |
71,589
+66,447
| +1,292% | +$2.57M | 0.34% | 70 |
|
|
2016
Q3 | $260K | Buy |
+5,142
| New | +$260K | 0.03% | 381 |
|
|
2014
Q3 | – | Sell |
-32,877
| Closed | -$488K | – | 356 |
|
|
2014
Q2 | $488K | Buy |
32,877
+11,840
| +56% | +$176K | 0.26% | 137 |
|
|
2014
Q1 | $339K | Buy |
+21,037
| New | +$339K | 0.17% | 219 |
|